EDGE: A Phase 3 study evaluating once versus twice daily dosing of eliglustat in patients with Gaucher disease type 1: interim results from the lead-in-period

✍ Scribed by Charrow, Joel; Ida, Hiroyuki; Hollak, Carla; Amato, Dominick; Cravo, Renata; Kawaguchi, Osamu; Xue, Yong

• Book ID: 122297194
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 52 KB
• Volume: 111
• Category: Article
• ISSN: 1096-7192
• DOI: 10.1016/j.ymgme.2013.12.053